Provided by Tiger Trade Technology Pte. Ltd.

Insulet

289.04
-3.8500-1.31%
Post-market: 289.040.00000.00%17:16 EST
Volume:902.31K
Turnover:258.75M
Market Cap:20.33B
PE:83.76
High:294.04
Open:293.08
Low:280.52
Close:292.89
52wk High:354.88
52wk Low:230.05
Shares:70.35M
Float Shares:70.08M
Volume Ratio:1.40
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.45
EPS(LYR):5.97
ROE:19.68%
ROA:8.74%
PB:14.69
PE(LYR):48.42

Loading ...

Insulet Is Maintained at Outperform by Bernstein

Dow Jones
·
7 hours ago

Bernstein Adjusts Price Target on Insulet to $380 From $410, Maintains Outperform Rating

MT Newswires Live
·
Yesterday

Insulet Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Yesterday

Insulet price target lowered to $365 from $388 at Goldman Sachs

TIPRANKS
·
Yesterday

RBC Capital Sticks to Their Buy Rating for Insulet (PODD)

TIPRANKS
·
Yesterday

Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 08

Insulet Showcases Liveable Diabetes Technology at CES

Reuters
·
Jan 06

Is Insulet Fairly Priced After Its Strong Run and High Earnings Multiple in 2025?

Simply Wall St.
·
Dec 22, 2025

Insulet Discloses Remediated IT Control Weakness in Financial Reporting

Reuters
·
Dec 20, 2025

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Dec 19, 2025

Truist Securities Lowers Price Target on Insulet to $390 From $412, Maintains Buy Rating

MT Newswires Live
·
Dec 18, 2025

Insulet Updates Annual Incentive Plan With Expanded Eligibility and Higher Awards

Reuters
·
Dec 18, 2025

Insulet Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Dec 18, 2025

Canaccord Genuity Adjusts Price Target on Insulet to $450 From $432, Maintains Buy Rating

MT Newswires Live
·
Dec 17, 2025

Insulet Corporation Director Wayne A.I. Frederick Reports Disposal of Common Shares

Reuters
·
Dec 17, 2025

Insulet Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Dec 16, 2025

Evercore ISI Initiates Coverage on Insulet With Outperform Rating, $370 Price Target

MT Newswires Live
·
Dec 16, 2025

Insulet Corporation to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 16, 2025

BUZZ-Insulet gets 'outperform' rating as Evercore starts coverage

Reuters
·
Dec 16, 2025

Insulet Corp : Evercore Isi Initiates Coverage With Outperform Rating; Target Price $370

THOMSON REUTERS
·
Dec 16, 2025